A detailed history of Alliancebernstein L.P. transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Alliancebernstein L.P. holds 20,010 shares of ANIP stock, worth $1.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,010
Previous 20,010 -0.0%
Holding current value
$1.13 Million
Previous $1.27 Million 6.36%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$58.53 - $68.82 $239,973 - $282,162
4,100 Added 25.77%
20,010 $1.27 Million
Q1 2024

May 14, 2024

BUY
$54.2 - $69.69 $88,346 - $113,594
1,630 Added 11.41%
15,910 $1.1 Million
Q2 2023

Aug 15, 2023

BUY
$37.29 - $53.83 $49,595 - $71,593
1,330 Added 10.27%
14,280 $768,000
Q1 2023

May 15, 2023

SELL
$37.61 - $45.72 $67,810 - $82,433
-1,803 Reduced 12.22%
12,950 $514,000
Q4 2022

Feb 14, 2023

BUY
$31.9 - $41.95 $1,052 - $1,384
33 Added 0.22%
14,753 $593,000
Q3 2022

Nov 15, 2022

SELL
$29.83 - $38.01 $4,027 - $5,131
-135 Reduced 0.91%
14,720 $473,000
Q2 2022

Aug 15, 2022

BUY
$23.09 - $33.46 $1,662 - $2,409
72 Added 0.49%
14,855 $441,000
Q1 2022

May 13, 2022

BUY
$26.91 - $47.15 $7,803 - $13,673
290 Added 2.0%
14,783 $416,000
Q4 2021

Feb 14, 2022

SELL
$32.97 - $56.85 $102,767 - $177,201
-3,117 Reduced 17.7%
14,493 $668,000
Q3 2021

Nov 10, 2021

SELL
$26.48 - $35.99 $11,916 - $16,195
-450 Reduced 2.49%
17,610 $578,000
Q2 2021

Jul 30, 2021

SELL
$31.86 - $38.6 $114,982 - $139,307
-3,609 Reduced 16.66%
18,060 $633,000
Q1 2021

May 06, 2021

BUY
$28.4 - $36.14 $63,900 - $81,315
2,250 Added 11.59%
21,669 $783,000
Q4 2020

Feb 08, 2021

BUY
$23.69 - $31.47 $28,593 - $37,984
1,207 Added 6.63%
19,419 $564,000
Q3 2020

Nov 12, 2020

SELL
$26.38 - $33.1 $18,835 - $23,633
-714 Reduced 3.77%
18,212 $514,000
Q2 2020

Aug 13, 2020

BUY
$29.93 - $50.1 $144,442 - $241,782
4,826 Added 34.23%
18,926 $612,000
Q1 2020

May 14, 2020

SELL
$30.35 - $67.14 $12,140 - $26,856
-400 Reduced 2.76%
14,100 $574,000
Q4 2019

Feb 18, 2020

BUY
$55.65 - $79.83 $2,782 - $3,991
50 Added 0.35%
14,500 $894,000
Q3 2019

Nov 14, 2019

SELL
$64.7 - $85.39 $109,990 - $145,163
-1,700 Reduced 10.53%
14,450 $1.05 Million
Q2 2019

Aug 14, 2019

BUY
$67.77 - $82.2 $399,843 - $484,980
5,900 Added 57.56%
16,150 $1.33 Million
Q2 2018

Aug 13, 2018

BUY
$56.38 - $68.08 $50,742 - $61,272
900 Added 9.63%
10,250 $685,000
Q1 2018

May 14, 2018

SELL
$56.98 - $72.41 $623,247 - $792,020
-10,938 Reduced 53.91%
9,350 $544,000
Q4 2017

Feb 13, 2018

BUY
$53.3 - $74.56 $577,665 - $808,081
10,838 Added 114.69%
20,288 $1.31 Million
Q3 2017

Nov 13, 2017

BUY
$43.46 - $52.49 $410,697 - $496,030
9,450
9,450 $496,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $986M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.